The merger transaction between Biofarma and Nutrilinea concluded today. The two companies, Italian excellences in the development and production of Health-Care products, brought to life Biofarma Group, a new strongly competitive industrial entity in the field of formulation, production and manufacturing, exclusively for third parties, of food supplements, medical devices, drugs containing probiotics and cosmetics. The new Group includes also three other companies of reference in the area: Apharm, Claire and Pharcoterm. This impressive productive entity complies with an ambitious project of industrial growth, with 650 collaborators allocated in four plants in different Italian regions: Friuli Venezia Giulia (where the headquarter in located in Mereto di Tomba – UD), Lombardia and Veneto. The company is positioned in first place in Italy in the Health Care products industry, with a turnover of 170 million euros (in 2019) and 170 productive lines, and it works towards reaching the top of the European market in few years. Today the Group works in more than 40 Countries in the world, and it aims to reach a turnover of 190 million euros in 2020.